PROK Stock Price
ProKidney Corp.
PROK stock price is $1.66 (+5.73% on the day), giving ProKidney Corp. a market cap of $474.65M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
PROK Stock Overview
- Price
- $1.66
- Previous close
- $1.57
- Open
- $1.55
- Market cap
- $474.65M
- P/E ratio
- -6.9
- 52-week range
- $1.30 - $3.48
- 1-year price target
- $5.50
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSC
- MarketXLS Rank
- 23
About ProKidney Corp.
ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States. Its lead product candidate, rilparencel, includes autologous selected renal cells (SRC) in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes. The company also develops a cryopreserved version of rilparencel that allows for long-term product preservation to be used in Phase 2 and 3 trials of rilparencel. ProKidney Corp. founded in 2015 and is based in Winston-Salem, North Carolina.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PROK | $1.66 | +5.7% | 1.13M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |